RE: Why PHE is MASSIVELY Undervalued. Todays RNS.1 Sep 2025 19:00
Red_hornet
Powerhouse Energy is not “banging the same drum.” Since 2023, they’ve acquired 100% of EngSolve, which has already delivered over £1 million in external projects in just the first four months of 2025. This is not hypothetical — it’s operational revenue with real clients including Repsol, Schlumberger, and Sound Energy.
Patents have been granted across the UK, EU, and the US. The Feedstock Testing Unit in Bridgend is live and operational. The Ballymena project has a signed Letter of Intent in place for exclusive hydrogen offtake, and is targeting first revenue in Q1 2028. Planning is part of the staged rollout. That’s normal — not a failure.
The Feedstock Testing Unit in Bridgend is live and running, with hydrogen yields validated and showcasing the patented rotary kiln system to potential partners. That’s not theory — it’s execution.
The Ballymena site is far from a vague ambition. There’s already a signed Letter of Intent for hydrogen offtake with B.S. Holdings. The plan is to deploy a full-scale 40-tonne-per-day DMG unit producing 3 tonnes of hydrogen daily and 1.3MW of power. Modelling for this single unit shows projected revenues of £11.5 million per year and a net present value of £13 million. That figure alone equates to nearly half of Powerhouse’s entire current market cap.
The 2.5-tonne DMG units, like those being lined up for Thailand and Project Eden, are designed to be profitable. They’re modular, easier to site, and offer commercial returns in the right use cases. They’re not just demonstrators — they are deployable, licensable units that expand market access and create revenue.
EngSolve, meanwhile, is already a profitable arm of the group. It delivers high-margin engineering consultancy, not only on DMG tech, but also across renewables and clean energy infrastructure. It’s winning business, generating cash flow, and supporting group operations without dilution.
Finally, yes, the March raise happened — but it was a strategic £1.325 million to accelerate progress on Ballymena, the Australian licensing rollout, new R&D, and EngSolve expansion. That’s proactive growth capital, not survival funding.
This is not the “same PHE story.” The company is executing a twin-track strategy with real-world traction, signed commercial partnerships, issued patents across three continents, and scalable IP-driven clean energy tech. The market cap of ~£28 million does not reflect the value of even one full-scale DMG unit, let alone the broader pipeline. The truth seems to keep passing you by. I wonder why?